| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Sharpe Ratio | ||
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
| 11.73 EUR | 0.11 EUR | 0.95 % |
|---|
| Vortag | 11.62 EUR | Datum | 30.01.2025 |
Franklin Biotechnology Discovery Fund A(acc) EUR-H1 Fonds Kurs - 1 Jahr
Anzeige
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Ripple XRP ETP | CH0454664043 | 492.66% | |
| 21Shares Stellar ETP | CH1109575535 | 355.78% | |
| 21Shares Stacks Staking ETP | CH1258969042 | 227.84% | |
| 21Shares Algorand ETP | CH1146882316 | 222.06% | |
| 21Shares Cardano ETP | CH1102728750 | 173.59% | |
| 21Shares Sui Staking ETP | CH1360612159 | 73.64% | |
| 21Shares Injective Staking ETP | CH1360612134 | -10.50% | |
| 21Shares Immutable ETP | CH1360612142 | -25.73% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Ripple XRP ETP | CH0454664043 | 401.70% | |
| 21Shares Sui Staking ETP | CH1360612159 | 384.21% | |
| 21Shares Stellar ETP | CH1109575535 | 321.86% | |
| 21Shares Aave ETP | CH1135202120 | 198.94% | |
| 21Shares Algorand ETP | CH1146882316 | 176.53% | |
| 21Shares Stacks Staking ETP | CH1258969042 | 145.10% | |
| 21Shares Injective Staking ETP | CH1360612134 | -28.68% | |
| 21Shares Immutable ETP | CH1360612142 | -32.41% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Ripple XRP ETP | CH0454664043 | 478.99% | |
| 21Shares Stellar ETP | CH1109575535 | 269.13% | |
| 21Shares Aave ETP | CH1135202120 | 229.27% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 223.35% | |
| 21Shares Crypto Mid-Cap Index ETP | CH1130675676 | 150.50% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Solana staking ETP | CH1114873776 | 928.17% | |
| 21Shares Ripple XRP ETP | CH0454664043 | 644.32% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 363.83% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | 353.91% | |
| 21Shares Stellar ETP | CH1109575535 | 352.14% |
Fundamentaldaten
| Valor | 41187139 |
| ISIN | LU1803069274 |
| Emittent | Franklin Templeton International Services |
| Aufgelegt in | Luxembourg |
| Auflagedatum | 06.04.2018 |
| Kategorie | Branchen: Andere Sektoren |
| Währung | EUR |
| Volumen | 1’251’440’415.19 |
| Depotbank | J.P. Morgan SE, Luxembourg Branch |
| Geschäftsjahresende | 30.06. |
| Berichtsstand | 31.01.2025 |
Anlagepolitik
So investiert der Franklin Biotechnology Discovery Fund A(acc) EUR-H1 Fonds: Anlageziel dieses Fonds ist das Kapitalwachstum.
Der Fonds investiert in erster Linie in Beteiligungspapiere von Biotech- und
Forschungsunternehmen in den USA und anderen Ländern und in geringerem Maße in Schuldtitel jeglicher Art von Emittenten rund um den Globus.
ETP Performance: Franklin Biotechnology Discovery Fund A(acc) EUR-H1 Fonds
| Performance 1 Jahr | -1.18 | |
| Performance 2 Jahre | 15.34 | |
| Performance 3 Jahre | 15.79 | |
| Performance 5 Jahre | 9.22 | |
| Performance 10 Jahre | - |